This is a routine passive disclosure by a small fund with no material implications. Monitor for any future conversion to a 13D filing if Nantahala increases its stake above 5% or engages with management.
YARW drugs
YARW drug pipeline →Price Chart
How similar events traded
Executive Summary
Nantahala Capital Management filed an amended Schedule 13G disclosing a 0.46% passive stake (39,198 shares) in Yarrow Bioscience as of September 30, 2026. This is a small, routine amendment with no material change from a prior filing; the stake is well below the 5% threshold and represents a negligible position relative to the company's $168M market cap.
Key Financial Metrics
Key Facts
- Nantahala Capital Management disclosed beneficial ownership of 39,198 shares of Yarrow Bioscience common stock as of September 30, 2026
- The stake represents 0.46% of shares outstanding
- The filing is an amendment to a Schedule 13G, indicating a passive investment intent
- The filing was made jointly by Nantahala Capital Management, Wilmot B. Harkey, and Daniel Mack
- No shares are held directly by the reporting persons; all 39,198 shares are held through funds and managed accounts under Nantahala's control
Financial Impact
Stake value approximately $773K based on $168M market cap and 9.44M shares outstanding (from prior 13G context); negligible relative to company size
Risk Factors
- No material risks identified from this filing; the stake is well below 5% and passive
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001104659-26-127183 |
| Document: 0001104659-26-127183-index.html | 0001104659-26-127183 |
| Document: 0001104659-26-127183.txt | 0001104659-26-127183 |
Track record
13 reports on YARW
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 17, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $14.20 Now $14.27 +0.49% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $13.93 Now $14.27 +2.44% settles Dec 16
- Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $15.44 Now $14.27 −7.58% settles Dec 15
- Nov 16, 20261d ago SC 13G Neutral 3/10 Entry $18.20 Now $14.27 −21.59% settles Dec 15
- Nov 16, 20261d ago SC 13G/A Neutral 3/10 Entry $18.03 Now $14.27 −20.85% settles Dec 15
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $17.35 Now $14.27 −17.75% settles Dec 15
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $18.03 Now $14.27 −20.85% settles Dec 15
- Nov 12, 20265d ago 8-K Neutral 4/10 Entry $19.63 Now $14.27 −27.31% settles Dec 11
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers